{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T21:38:15Z","timestamp":1775252295783,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.canrad.2016.12.004","type":"journal-article","created":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T19:30:19Z","timestamp":1494358219000},"page":"267-275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Int\u00e9r\u00eat de la tomographie par \u00e9mission de positons au (18F)-fluorod\u00e9soxyglucose pour la planification de la radioth\u00e9rapie des cancers de l\u2019\u0153sophage localement \u00e9volu\u00e9s ou inop\u00e9rables"],"prefix":"10.1016","volume":"21","author":[{"given":"J.","family":"Encaoua","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Abgral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Leleu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"El Kabbaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Caradec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Bourhis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Pradier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Schick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2016.12.004_bib0170","series-title":"Estimation nationale de l\u2019incidence et de la mortalit\u00e9 par cancer en France entre 1980\u00a0et 2012. Partie 1\u2013Tumeurs solides","author":"Binder-Foucard","year":"2013"},{"key":"10.1016\/j.canrad.2016.12.004_bib0175","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/bjs.5358","article-title":"Impact of preoperative radiochemotherapy on postoperative course and survival in patients with locally advanced squamous cell oesophageal carcinoma","volume":"93","author":"Mariette","year":"2006","journal-title":"Br J Surg"},{"key":"10.1016\/j.canrad.2016.12.004_bib0180","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S1470-2045(15)00040-6","article-title":"Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (Cross): long-term results of a randomised controlled trial","volume":"16","author":"Shapiro","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2016.12.004_bib0185","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1200\/JCO.2013.53.6532","article-title":"Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901","volume":"32","author":"Mariette","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2016.12.004_bib0190","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"Van Hagen","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2016.12.004_bib0195","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1016\/j.canrad.2016.07.039","article-title":"Radioth\u00e9rapie des cancers de l\u2019\u0153sophage, du cardia et de l\u2019estomac","volume":"20","author":"Cr\u00e9hange","year":"2016","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2016.12.004_bib0200","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1056\/NEJM199206113262403","article-title":"Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus","volume":"326","author":"Herskovic","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2016.12.004_bib0205","doi-asserted-by":"crossref","first-page":"LBA4003","DOI":"10.1200\/jco.2012.30.18_suppl.lba4003","article-title":"Phase III randomized trial of definitive chemoradiotherapy (CRT) with folfox or cisplatin and fluorouracil in esophageal cancer (EC): final results of the Prodige 5\/Accord 17\u00a0trial","volume":"30","author":"Conroy","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2016.12.004_bib0210","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.canrad.2016.07.065","article-title":"D\u00e9termination des marges du volume cible anatomoclinique au volume cible pr\u00e9visionnel pour la radioth\u00e9rapie conformationnelle des cancers de l\u2019\u0153sophage","volume":"20","author":"Lesueur","year":"2016","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2016.12.004_bib0215","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00261-007-9241-1","article-title":"Role of PET\/PET CT in the staging and restaging of thoracic oesophageal cancer and gastro-oesophageal cancer: a literature review","volume":"33","author":"Wong","year":"2008","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.canrad.2016.12.004_bib0220","doi-asserted-by":"crossref","first-page":"864","DOI":"10.2967\/jnumed.111.101568","article-title":"(18F)-FDG PET\/CT has a high impact on patient management and provides powerful prognostic stratification in the primary staging of esophageal cancer: a prospective study with mature survival data","volume":"53","author":"Barber","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1016\/j.canrad.2016.12.004_bib0225","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.radonc.2015.06.007","article-title":"Primary tumor delineation based on (18F)-FDG PET for locally advanced head and neck cancer treated by chemo-radiotherapy","volume":"116","author":"Leclerc","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2016.12.004_bib0230","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3389\/fonc.2014.00273","article-title":"The utility of positron emission tomography in the treatment planning of image-guided radiotherapy for non-small cell lung cancer","volume":"4","author":"Chi","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/j.canrad.2016.12.004_bib0235","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ijrobp.2003.10.044","article-title":"Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer","volume":"59","author":"Bradley","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.12.004_bib0240","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0360-3016(01)01824-7","article-title":"The impact of (18F)-FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study","volume":"52","author":"Mah","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.12.004_bib0245","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1245\/s10434-010-1024-1","article-title":"7th Edition of the AJCC Cancer staging manual: esophagus and esophagogastric junction","volume":"17","author":"Rice","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.canrad.2016.12.004_bib0250","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0167-8140(03)00270-6","article-title":"Tri-dimensional automatic segmentation of PET volumes based on measured source-to-background ratios: influence of reconstruction algorithms","volume":"69","author":"Daisne","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2016.12.004_bib0255","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.canrad.2013.07.145","article-title":"Clinical target volume delineation for radiotherapy of the esophagus","volume":"17","author":"Lazarescu","year":"2013","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2016.12.004_bib0260","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijrobp.2006.09.033","article-title":"Impact of hybrid fluorodeoxyglucose positron-emission tomography\/computed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer","volume":"67","author":"Gondi","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.12.004_bib0265","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.radonc.2010.10.006","article-title":"Gradient-based delineation of the primary GTV on FDG-PET in non-small cell lung cancer: a comparison with threshold-based approaches, CT and surgical specimens","volume":"98","author":"Wanet","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2016.12.004_bib0270","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.radonc.2014.11.004","article-title":"Involved-field irradiation concurrently combined with nedaplatin\/5-fluorouracil for inoperable esophageal cancer on basis of (18F)-FDG-PET scans: a phase II study","volume":"113","author":"Yamashita","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2016.12.004_bib0275","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.radonc.2009.08.030","article-title":"Consequences of additional use of PET information for target volume delineation and radiotherapy dose distribution for esophageal cancer","volume":"93","author":"Muijs","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2016.12.004_bib0280","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.clon.2014.11.006","article-title":"Defining the target in cancer of the oesophagus: direct radiotherapy planning with fluorodeoxyglucose positron emission tomography-computed tomography","volume":"27","author":"Le Grange","year":"2015","journal-title":"Clin Oncol"},{"key":"10.1016\/j.canrad.2016.12.004_bib0285","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.ijrobp.2004.07.717","article-title":"The integration of (18F)-fluoro-deoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma","volume":"61","author":"Konski","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.12.004_bib0290","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.radonc.2015.07.007","article-title":"Tumour delineation in oesophageal cancer \u2013 a prospective study of delineation in PET and CT with and without endoscopically placed clip markers","volume":"116","author":"Thomas","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2016.12.004_bib0295","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ijrobp.2014.06.028","article-title":"Radiobiological determination of dose escalation and normal tissue toxicity in definitive chemoradiation therapy for esophageal cancer","volume":"90","author":"Warren","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.12.004_bib0300","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.radonc.2014.12.007","article-title":"Safety of dose escalation by simultaneous integrated boosting radiation dose within the primary tumor guided by (18F)-FDG-PET\/CT for esophageal cancer","volume":"114","author":"Yu","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2016.12.004_bib0305","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2967\/jnumed.114.145029","article-title":"Update on time-of-flight pet imaging","volume":"56","author":"Surti","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1016\/j.canrad.2016.12.004_bib0310","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2197-7364-1-12","article-title":"The influence of different signal-to-background ratios on spatial resolution and (18F)-FDG-PET quantification using point spread function and time-of-flight reconstruction","volume":"1","author":"Rogasch","year":"2014","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.canrad.2016.12.004_bib0315","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ijrobp.2009.02.078","article-title":"Three-dimensional conformal radiation therapy for esophageal squamous cell carcinoma: is elective nodal irradiation necessary?","volume":"76","author":"Zhao","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.12.004_bib0320","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/cncr.20724","article-title":"The Incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma","volume":"103","author":"Kato","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2016.12.004_bib0325","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.ijrobp.2009.07.1681","article-title":"Comparison Of (18)F-fluorothymidine and (18F)-fluorodeoxyglucose PET\/CT in delineating gross tumor volume by optimal threshold in patients with squamous cell carcinoma of thoracic esophagus","volume":"76","author":"Han","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2016.12.004_bib0165","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.radonc.2012.10.015","article-title":"Oesophageal tumour progression between the diagnostic (18F)-FDG-PET and the (18F)-FDG-PET for radiotherapy treatment planning","volume":"106","author":"Muijs","year":"2013","journal-title":"Radiother Oncol"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321817300641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321817300641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:25:44Z","timestamp":1761135944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321817300641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S1278321817300641"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2016.12.004","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Int\u00e9r\u00eat de la tomographie par \u00e9mission de positons au (18F)-fluorod\u00e9soxyglucose pour la planification de la radioth\u00e9rapie des cancers de l\u2019\u0153sophage localement \u00e9volu\u00e9s ou inop\u00e9rables","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2016.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}